authors
- Campos, SM
- Seiden, MV
- Oza, A
- Plante, M
- Potkul, R
- Hamid, O
- Lenehan, P
- Kaldjian, E
- Jordan, C
- Hirte, Holger
A phase 2, single agent study of Cl-1033 administered at two doses in ovarian cancer patients who failed platinum therapy.
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- July 15, 2004
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Journal of Clinical Oncology Journal